Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5034)
All Articles published online
|
Jun 7, 2012 (publication date) through Dec 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cereda S, Belli C, Reni M. Adjuvant treatment in biliary tract cancer: To treat or not to treat? World J Gastroenterol 2012; 18(21): 2591-2596 [PMID: 22690066 DOI: 10.3748/wjg.v18.i21.2591] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i21/2591.htm |
| Number | Citing Articles |
| 1 |
KWAN WOO KIM, HYUK-CHAN KWON, SUNG-HYUN KIM, SUNG YONG OH, SUEE LEE, JI HYUN LEE, MYUNG HWAN ROH, MIN CHAN KIM, KI HAN KIM, YOUNG HOON KIM, YOUNG HOON ROH, JIN SOOK JEONG, HYO-JIN KIM. Prognostic significance of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in biliary tract cancer patients receiving adjuvant 5-fluorouracil-based chemotherapy. Molecular and Clinical Oncology 2013; 1(6): 987 doi: 10.3892/mco.2013.166
|
| 2 |
Ka Wing Ma, Tan To Cheung, Wong Hoi She, Kenneth Siu Ho Chok, Albert Chi Yan Chan, Wing Chiu Dai, Wan Hang Chiu, Chung Mau Lo. Diagnostic and Prognostic Role of 18‐FDG PET/CT in the Management of Resectable Biliary Tract Cancer. World Journal of Surgery 2018; 42(3): 823 doi: 10.1007/s00268-017-4192-3
|
| 3 |
Bradley A. Krasnick, Linda X. Jin, Jesse T. Davidson, Dominic E. Sanford, Cecilia G. Ethun, Timothy M. Pawlik, George A. Poultsides, Thuy Tran, Kamran Idrees, William G. Hawkins, William C. Chapman, Maria B.M. Doyle, Sharon M. Weber, Steven M. Strasberg, Ahmed Salem, Robert C.G. Martin, Chelsea A. Isom, Charles Scoggins, Carl R. Schmidt, Perry Shen, Eliza Beal, Ioannis Hatzaras, Rivfka Shenoy, Shishir K. Maithel, Ryan C. Fields. Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi‐institution analysis from the U.S. extrahepatic biliary malignancy consortium. Journal of Surgical Oncology 2018; 117(3): 363 doi: 10.1002/jso.24836
|
| 4 |
Jonathan Navarro, Incheon Kang, Ho Kyoung Hwang, Dong Sup Yoon, Woo Jung Lee, Chang Moo Kang. Glucose to Lymphocyte Ratio as a Prognostic Marker in Patients With Resected pT2 Gallbladder Cancer. Journal of Surgical Research 2019; 240: 17 doi: 10.1016/j.jss.2019.02.043
|
| 5 |
Jieun Lee, Do Hoon Lim, Hee Chul Park, Jeong Il Yu, Dong Wook Choi, Seong Ho Choi, Jin Seok Heo. Predictive factors of gastroduodenal bleeding after postoperative radiotherapy in biliary tract cancer. Japanese Journal of Clinical Oncology 2017; 47(4): 328 doi: 10.1093/jjco/hyw205
|
| 6 |
Amit Bahl, Tapesh Bhattacharyya, Rakesh Kapoor, Oinam A. Singh, Tomar Parsee, Suresh C. Sharma. Postoperative Radiotherapy in Periampullary Cancers: A Brief Review. Journal of Gastrointestinal Cancer 2013; 44(1): 111 doi: 10.1007/s12029-012-9421-2
|
| 7 |
Alessandro Cannavale, Mariangela Santoni, Marianna Gazzetti, Ben Maher, Fabrizio Fanelli, Fausto Fiocca, Carlo Catalano. Updated Management of Malignant Biliary Tract Tumors: An Illustrative Review. Journal of Vascular and Interventional Radiology 2016; 27(7): 1056 doi: 10.1016/j.jvir.2016.01.149
|
| 8 |
Zhi-Peng Liu, Wei-Yue Chen, Zi-Ran Wang, Xing-Chao Liu, Hai-Ning Fan, Lei Xu, Yu Pan, Shi-Yun Zhong, Dan Xie, Jie Bai, Yan Jiang, Yan-Qi Zhang, Hai-Su Dai, Zhi-Yu Chen. Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.849053
|
| 9 |
A. Boukir, I. Azghari, M. El Kabous, I. El Ghissassi, S. Boutayeb, H. Mrabti, H. Errihani. Place de la chimiothérapie dans la prise en charge des cancers des voies biliaires. Journal Africain d'Hépato-Gastroentérologie 2015; 9(4): 166 doi: 10.1007/s12157-015-0614-8
|
| 10 |
Lejia Sun, Xin Ji, Dongyue Wang, Ai Guan, Yao Xiao, Haifeng Xu, Shunda Du, Yiyao Xu, Haitao Zhao, Xin Lu, Xinting Sang, Shouxian Zhong, Huayu Yang, Yilei Mao. Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07496-8
|
| 11 |
Kyun Woo Park, Eun-Seon Jung, Dong-Gu Kim, Young-Kyung Yoo, Tae-Ho Hong, In Seok Lee, Yoon Ho Koh, Ji-Hoon Kim, Myung Ah Lee. ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma. Cancer Research and Treatment 2013; 45(1): 63 doi: 10.4143/crt.2013.45.1.63
|
| 12 |
Rondell P. Graham, Emily G. Barr Fritcher, Ekaterina Pestova, John Schulz, Leonid A. Sitailo, George Vasmatzis, Stephen J. Murphy, Robert R. McWilliams, Steven N. Hart, Kevin C. Halling, Lewis R. Roberts, Gregory J. Gores, Fergus J. Couch, Lizhi Zhang, Mitesh J. Borad, Benjamin R. Kipp. Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma. Human Pathology 2014; 45(8): 1630 doi: 10.1016/j.humpath.2014.03.014
|
| 13 |
Xiao-Hong Pu, Qing Ye, Jun Yang, Hong-Yan Wu, Xi-Wei Ding, Jiong Shi, Liang Mao, Xiang-Shan Fan, Jun Chen, Yu-Dong Qiu, Qin Huang. Low-level clonal FGFR2 amplification defines a unique molecular subtype of intrahepatic cholangiocarcinoma in a Chinese population. Human Pathology 2018; 76: 100 doi: 10.1016/j.humpath.2017.12.028
|
| 14 |
Leila T. Tchelebi, Krishan R. Jethwa, Anna T. Levy, Christopher J. Anker, Timothy Kennedy, Elliot Grodstein, Christopher L. Hallemeier, Salma K. Jabbour, Ed Kim, Rachit Kumar, Percy Lee, William Small, Vonetta M. Williams, Navesh Sharma, Suzanne Russo. American Radium Society (ARS) Appropriate Use Criteria (AUC) for Extrahepatic Cholangiocarcinoma. American Journal of Clinical Oncology 2023; 46(2): 73 doi: 10.1097/COC.0000000000000969
|
| 15 |
Young Saing Kim, Chi-Young Jeong, Haa-Na Song, Tae Hyo Kim, Hong Jun Kim, Young-Joon Lee, Soon Chan Hong. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection. Chinese Journal of Cancer 2017; 36(1) doi: 10.1186/s40880-017-0182-y
|
| 16 |
Michele Ghidini, Luciano Cascione, Pietro Carotenuto, Andrea Lampis, Francesco Trevisani, Maria Chiara Previdi, Jens C. Hahne, Ian Said-Huntingford, Maya Raj, Alessandro Zerbi, Claudia Mescoli, Umberto Cillo, Massimo Rugge, Massimo Roncalli, Guido Torzilli, Lorenza Rimassa, Armando Santoro, Nicola Valeri, Matteo Fassan, Chiara Braconi. Characterisation of the immune-related transcriptome in resected biliary tract cancers. European Journal of Cancer 2017; 86: 158 doi: 10.1016/j.ejca.2017.09.005
|
| 17 |
Zachary J. Brown, Daniel B. Hewitt, Timothy M. Pawlik. Gallbladder Cancer. 2023; : 75 doi: 10.1007/978-981-19-6442-8_4
|
| 18 |
Rachel RIECHELMANN, Anelisa K COUTINHO, Rui F WESCHENFELDER, Gustavo ANDRADE DE PAULO, Gustavo dos Santos FERNANDES, Markus GIFONI, Maria de Lourdes OLIVEIRA, Rene GANSL, Roberto GIL, Gustavo LUERSEN, Lucio LUCAS, Marcio REISNER, Fernando Meton VIEIRA, Marcel Autran MACHADO, Andre MURAD, Alessandro OSVALDT, Miguel BRANDÃO, Elisangela CARVALHO, Tulio SOUZA, Tulio PFIFFER, Gabriel PROLLA. GUIDELINE FOR THE MANAGEMENT OF BILE DUCT CANCERS BY THE BRAZILIAN GASTROINTESTINAL TUMOR GROUP. Arquivos de Gastroenterologia 2016; 53(1): 5 doi: 10.1590/S0004-28032016000100003
|
| 19 |
Santosh Kumar Singh, Rajnish Talwar, Narayanan Kannan, Arvind Kumar Tyagi, Pradeep Jaiswal, Adarsh Kumar. Patterns of Presentation, Treatment, and Survival Rates of Gallbladder Cancer: a Prospective Study at a Tertiary Care Centre. Journal of Gastrointestinal Cancer 2018; 49(3): 268 doi: 10.1007/s12029-017-9940-y
|
| 20 |
Jitlada Juengsamarn, Chatsuda Sookthon, Kaewta Jeerapradit, Kanin Sriudomporn, Satsawat Chansitthichok, Weeris Ouransatien, Wikran Suragul, Sujitra Boonpob, Poowanai Sarkhampee, Nuttapong Ngamphaiboon. Predictive MINT Pathologic Risk Score for Adjuvant Chemotherapy in Resected Cholangiocarcinoma: A Propensity Score–Matched Multicenter Study in Thailand. JCO Global Oncology 2024; (10) doi: 10.1200/GO-24-00286
|
| 21 |
Zhijun Yuan, Yongjie Shui, Lihong Liu, Yinglu Guo, Qichun Wei. Postoperative recurrent patterns of gallbladder cancer: possible implications for adjuvant therapy. Radiation Oncology 2022; 17(1) doi: 10.1186/s13014-022-02091-6
|
| 22 |
Se-Il Go, Young Saing Kim, In Gyu Hwang, Eun Young Kim, Sung Yong Oh, Jun Ho Ji, Haa-Na Song, Se Hoon Park, Joon Oh Park, Jung Hun Kang. Is There a Role for Adjuvant Therapy in R0 Resected Gallbladder Cancer?: A Propensity Score-Matched Analysis. Cancer Research and Treatment 2016; 48(4): 1274 doi: 10.4143/crt.2015.502
|
| 23 |
Hyo Chun Lee, Jong Hoon Lee, Sea-Won Lee, Joo Hwan Lee, Mina Yu, Hong Seok Jang, Sung Hwan Kim. Retrospective analysis of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy of postoperative treatment for biliary tract cancer. Radiation Oncology Journal 2019; 37(4): 279 doi: 10.3857/roj.2019.00430
|